Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Pre-operative IRX-2 in Early Stage Breast Cancer (ESBC)

This study is currently recruiting participants. (see Contacts and Locations)
Verified March 2017 by Providence Health & Services
Sponsor:
Collaborator:
IRX Therapeutics
Information provided by (Responsible Party):
Providence Health & Services
ClinicalTrials.gov Identifier:
NCT02950259
First received: October 28, 2016
Last updated: March 1, 2017
Last verified: March 2017
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: November 2018
  Estimated Primary Completion Date: April 2018 (Final data collection date for primary outcome measure)